Alnylam Pharmaceuticals Ready To Go With Its Next Blockbuster

Waiting is often the most frustrating part of biotech investing, as the stocks can drift without clear positive drivers, and such has been the case with Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) for much of the past year, withAnalyst’s Disclosure: I/we have a beneficial long position in the shares of ALNY, RHHBY either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alph ...